miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming. Indian Journal of Biochemistry and Biophysics (IJBB), [S. l.], v. 60, n. 3, p. 167–176, 2023. DOI: 10.56042/ijbb.v60i3.66526. Disponível em: https://or.niscpr.res.in/index.php/IJBB/article/view/3345. Acesso em: 8 jul. 2026.